Altman Peter: insider trades.
Altman Peter reported 15 non-derivative transactions on 12 SEC ownership filings in Q3 2026: 13 open-market purchases ($31K) and 0 sales, across 1 company.
- Transactions
- 15
- Purchases (P)
- 13
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Altman Peter
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BioCardia, Inc. (BCDA) | Director, Officer · President and CEO | 15 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | BioCardia, Inc. | P | 1,000 | $1.03 | 384,885 | Form 4 |
| 2026-09-23 | BioCardia, Inc. | P | 1,900 | $1.05 | 383,885 | Form 4 |
| 2026-09-03 | BioCardia, Inc. | P | 800 | $1.09 | 381,985 | Form 4 |
| 2026-08-17 | BioCardia, Inc. | P | 5,400 | $0.93 | 381,115 | Form 4 |
| 2026-08-13 | BioCardia, Inc. | P | 1,900 | $0.92 | 375,785 | Form 4 |
| 2026-07-29 | BioCardia, Inc. | P | 5,000 | $0.78 | 373,885 | Form 4 |
| 2026-07-17 | BioCardia, Inc. | P | 500 | $0.83 | 368,885 | Form 4 |
| 2026-07-15 | BioCardia, Inc. | P | 1,500 | $0.86 | 368,385 | Form 4 |
| 2026-07-14 | BioCardia, Inc. | P | 2,800 | $0.88 | 366,885 | Form 4 |
| 2026-07-10 | BioCardia, Inc. | P | 1,000 | $0.94 | 369,485 | Form 4 |
| 2026-07-09 | BioCardia, Inc. | P | 1,000 | $0.9 | 368,485 | Form 4 |
| 2026-07-08 | BioCardia, Inc. | P | 5,500 | $0.97 | 367,485 | Form 4 |
| 2026-07-08 | BioCardia, Inc. | P | 5,400 | $0.96 | 361,985 | Form 4 |
| 2026-07-02 | BioCardia, Inc. | F | 54,606 | $1.24 | 356,585 | Form 4 |
| 2026-06-29 | BioCardia, Inc. | A | 110,625 | $1.2 | 411,191 | Form 4 |
Questions
What stock did Altman Peter buy or sell?
Altman Peter reported 15 non-derivative transactions on 12 SEC ownership filings in Q3 2026: 13 open-market purchases ($31K) and 0 sales, across 1 company.
Is Altman Peter the same person as other filers with this name?
This page covers SEC CIK 1647542 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/altman-peter-1647542.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.